TY - JOUR
T1 - Stereotactic radiosurgery for intracranial meningiomas
T2 - Current concepts and future perspectives
AU - Mansouri, Alireza
AU - Guha, Daipayan
AU - Klironomos, George
AU - Larjani, Soroush
AU - Zadeh, Gelareh
AU - Kondziolka, Douglas
N1 - Publisher Copyright:
© 2015 by the Congress of Neurological Surgeons.
PY - 2015/4/19
Y1 - 2015/4/19
N2 - Meningiomas are among the most common adult brain tumors. Although the optimal management of meningiomas would provide complete elimination of the lesion, this cannot always be accomplished safely through resection. Therefore, other therapeutic modalities, such as stereotactic radiosurgery (as primary or adjunctive therapy), have emerged. In the current review, we have provided an overview of the historical outcomes of various radiosurgical modalities applied in the management of meningiomas. Furthermore, we provide a discussion on key factors (eg World Health Organization grade, lesion size, and lesion location) that affect tumor control and adverse event rates. We discuss recent changes in our understanding of meningiomas, based on molecular and genetic markers, and how these will change our perspective on the management of meningiomas. We conclude by outlining the areas in which knowledge gaps persist and provide suggestions as to how these can be addressed.
AB - Meningiomas are among the most common adult brain tumors. Although the optimal management of meningiomas would provide complete elimination of the lesion, this cannot always be accomplished safely through resection. Therefore, other therapeutic modalities, such as stereotactic radiosurgery (as primary or adjunctive therapy), have emerged. In the current review, we have provided an overview of the historical outcomes of various radiosurgical modalities applied in the management of meningiomas. Furthermore, we provide a discussion on key factors (eg World Health Organization grade, lesion size, and lesion location) that affect tumor control and adverse event rates. We discuss recent changes in our understanding of meningiomas, based on molecular and genetic markers, and how these will change our perspective on the management of meningiomas. We conclude by outlining the areas in which knowledge gaps persist and provide suggestions as to how these can be addressed.
UR - http://www.scopus.com/inward/record.url?scp=84925146454&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925146454&partnerID=8YFLogxK
U2 - 10.1227/NEU.0000000000000633
DO - 10.1227/NEU.0000000000000633
M3 - Review article
C2 - 25599213
AN - SCOPUS:84925146454
SN - 0148-396X
VL - 76
SP - 362
EP - 371
JO - Neurosurgery
JF - Neurosurgery
IS - 4
ER -